23 related articles for article (PubMed ID: 11062142)
1. Analyzing the Effects of Single Nucleotide Polymorphisms on hnRNPA2/B1 Protein Stability and Function: Insights for Anticancer Therapeutic Design.
Dutta K; Kravtsov V; Oleynikova K; Ruzov A; Skorb EV; Shityakov S
ACS Omega; 2024 Feb; 9(5):5485-5495. PubMed ID: 38343990
[TBL] [Abstract][Full Text] [Related]
2. Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.
Berasain C; Elizalde M; Urtasun R; Castillo J; García-Irigoyen O; Uriarte I; Latasa MU; Prieto J; Avila MA
Hepat Oncol; 2014 Apr; 1(2):241-252. PubMed ID: 30190958
[TBL] [Abstract][Full Text] [Related]
3. Insights into the roles of hnRNP A2/B1 and AXL in non-small cell lung cancer.
Qu XH; Liu JL; Zhong XW; Li XI; Zhang QG
Oncol Lett; 2015 Sep; 10(3):1677-1685. PubMed ID: 26622731
[TBL] [Abstract][Full Text] [Related]
4. Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues.
Boukakis G; Patrinou-Georgoula M; Lekarakou M; Valavanis C; Guialis A
BMC Cancer; 2010 Aug; 10():434. PubMed ID: 20716340
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma.
Cui H; Wu F; Sun Y; Fan G; Wang Q
BMC Cancer; 2010 Jul; 10():356. PubMed ID: 20604928
[TBL] [Abstract][Full Text] [Related]
6. Considerations in developing successful, population-based molecular screening and prevention of lung cancer.
Mulshine JL; De Luca LM; Dedrick RL; Tockman MS; Webster R; Placke ME
Cancer; 2000 Dec; 89(11 Suppl):2465-7. PubMed ID: 11147628
[TBL] [Abstract][Full Text] [Related]
7. Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer.
Zhou J; Nong L; Wloch M; Cantor A; Mulshine JL; Tockman MS
Lung Cancer; 2001 Dec; 34(3):341-50. PubMed ID: 11714531
[TBL] [Abstract][Full Text] [Related]
8. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
Tockman MS; Mulshine JL; Piantadosi S; Erozan YS; Gupta PK; Ruckdeschel JC; Taylor PR; Zhukov T; Zhou WH; Qiao YL; Yao SX
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2237-46. PubMed ID: 9815620
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
Zech VF; Dlaska M; Tzankov A; Hilbe W
Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.
Sueoka E; Goto Y; Sueoka N; Kai Y; Kozu T; Fujiki H
Cancer Res; 1999 Apr; 59(7):1404-7. PubMed ID: 10197602
[TBL] [Abstract][Full Text] [Related]
11. Altered expression of splicing factor, heterogeneous nuclear ribonucleoprotein A2/B1, in mouse lung neoplasia.
Peebles KA; Dwyer-Nield LD; Malkinson AM
Mol Carcinog; 2007 Nov; 46(11):887-900. PubMed ID: 17477362
[TBL] [Abstract][Full Text] [Related]
12. Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations.
Man YG; Martinez A; Avis IM; Hong SH; Cuttitta F; Venzon DJ; Mulshine JL
Am J Respir Cell Mol Biol; 2000 Nov; 23(5):636-45. PubMed ID: 11062142
[TBL] [Abstract][Full Text] [Related]
13. Clinical detection of lung cancer progression markers.
Tockman MS
J Cell Biochem Suppl; 1996; 25():177-84. PubMed ID: 9027616
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
